HOME › COMPANIES › IONIS PHARMACEUTICALS
LARGE / MID-CAP BIOPHARMA

IONIS PHARMACEUTICALS (IONS)

California, USA · North America
NEUROLOGY
CARDIOMETABOLIC
RARE DISEASES
LARGE / MID-CAP BIOPHARMA
HEADQUARTERS
California, USA
TICKER
IONS
SEGMENT
Large / Mid-cap Biopharma
THERAPY AREAS
Neurology, cardiometabolic, rare diseases
KEY PRODUCTS
PRODUCTDETAILS
Spinraza (royalties)—
Tegsedi—
COMPANY OVERVIEW

Pioneer in antisense oligonucleotide therapeutics with partnered and wholly owned programs.

IONIS PHARMACEUTICALS — FULL INTELLIGENCE

Live regulatory signals, patent cliffs, financials, tariff exposure and pipeline — all free on PharmaSignal.

OPEN PLATFORM →